EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

In Vitro Models of Diabetes: Focus on Diabetic Retinopathy

Giulia Galgani iD, Giorgia Bray iD, Alma Martelli iD, Vincenzo Calderone, Valentina Citi

Cells · 11.11.2024 · 13 (22) · 1864

DOI: 10.3390/cells13221864 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 11.11.2024. Verfasst von Giulia Galgani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Diabetic Retinopathy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Experimental Pharmacology and Biology, Farmigea S.p.a.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy is a major eye complication in patients with diabetes mellitus, and it is the leading cause of blindness and visual impairment in the world. Chronic hyperglycemia induces endothelial damage with consequent vascular lesions, resulting in global vasculitis, which affects the small vessels of the retina. These vascular lesions cause ischemic conditions in certain areas of the retina, with a consequent increase in the release of pro-angiogenic mediators. In addition to pharmacological interventions for controlling the blood glycaemic level, the main strategies for treating diabetic retinopathy are the intravitreal injections of drugs, surgical treatments, and vitrectomies. The complexity of diabetic retinopathy is due to its close interactions with different cell types (endothelial cells, astrocytes, and Müller cells). The evaluation of the efficacy of novel pharmacological strategies is mainly performed through in vivo models. However, the use of different animal species leads to heterogenic results and ethical concerns. For these reasons, the development of new and reliable in vitro models, such as cell co-cultures and eye organoids, represents an urgent need in this area of research. This review features an overview of the in vitro models used to date and highlights the advances in technology used to study this pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyHumansAnimalsModels, BiologicalEndothelial CellsDiabetes Mellitus

Stichwörter der Autor:innen

alternative modelscell culturesdiabetic retinopathyin vitro modelsorganoids

Autor:innen und Institutionen

  • Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
  • Interuniversity Centre for the Promotion of the 3R Principles in Teaching and Research, Italy.

ORCID-Profile: Giulia Galgani, Giorgia Bray, Alma Martelli

Förderung

  • Institute of Experimental Pharmacology and Biology
  • Farmigea S.p.a

Zitieren

APA

Galgani, G., Bray, G., Martelli, A., Calderone, V., & Citi, V. (2024). In Vitro Models of Diabetes: Focus on Diabetic Retinopathy. Cells, 13(22), 1864. https://doi.org/10.3390/cells13221864

Vancouver

Galgani G, Bray G, Martelli A, Calderone V, Citi V. In Vitro Models of Diabetes: Focus on Diabetic Retinopathy. Cells. 2024;13(22):1864. doi:10.3390/cells13221864

BibTeX
@article{Galgani2024,
  author = {Galgani, Giulia and Bray, Giorgia and Martelli, Alma and Calderone, Vincenzo and Citi, Valentina},
  title = {In Vitro Models of Diabetes: Focus on Diabetic Retinopathy},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {22},
  pages = {1864},
  doi = {10.3390/cells13221864}
}
Kostenlos starten →